TSX Delisting Review - Appili Therapeutics Inc. (APLI)

September 3, 2026
Issuer: Appili Therapeutics Inc. (the "Company")
Securities:

Class A Common Shares

Symbol(s):

APLI

Delisting Review Type: Remedial
Delisting Review Period: TSX has decided to further extend its review of the eligibility of the Class A Common Shares of the Company for continued listing for a period of 30 days.
Additional Information: Please refer to TSX Bulletin 2026-0757 dated August 6, 2026.
TSX Contact: Anne Child,
Managing Director,
TSX Listings